Literature DB >> 8363634

Changes in monoamine oxidase activity in mouse brain associated with d-methamphetamine dependence and withdrawal.

T Egashira1, Y Yamanaka.   

Abstract

The long-term effects of d-methamphetamine (MP, 5 mg/kg) on brain mitochondrial monoamine oxidase (MAO) activity were studied in mice given MP intraperitoneally daily for 4 weeks. The MAO activities decreased when serotonin (5-HT) and dopamine (DA) were used as substrates. A marked elevation in MAO activity was seen during MP withdrawal when 5-HT, DA, beta-phenylethylamine (beta-PEA) and norepinephrine (NE) were used as substrates. The kinetics of MAO showed a significant decrease in Km values, but no significant change in Vmax values during MP withdrawal, despite the presence of NE. The Km and Vmax values increased when NE was the substrate. Inhibition of MAO by MP or its metabolites (amphetamine, p-hydroxyamphetamine and p-hydroxymethamphetamine) increased with the use of the following substrates in the order: DA, 5-HT, NE and beta-PEA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8363634     DOI: 10.1016/0006-2952(93)90545-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  4 in total

1.  Mouse strain- and age-dependent effects of binge methamphetamine on dopaminergic signaling.

Authors:  Renee L Good; Li-Ping Liang; Manisha Patel; Richard A Radcliffe
Journal:  Neurotoxicology       Date:  2011-07-20       Impact factor: 4.294

2.  Abstinence from repeated amphetamine treatment induces depressive-like behaviors and oxidative damage in rat brain.

Authors:  Yi Che; Yong-Hua Cui; Hua Tan; Ana C Andreazza; L Trevor Young; Jun-Feng Wang
Journal:  Psychopharmacology (Berl)       Date:  2013-02-01       Impact factor: 4.530

Review 3.  Neurochemical consequences of dysphoric state during amphetamine withdrawal in animal models: a review.

Authors:  Junichi Kitanaka; Nobue Kitanaka; Motohiko Takemura
Journal:  Neurochem Res       Date:  2007-06-29       Impact factor: 3.996

Review 4.  Current and Emerging Treatments for Methamphetamine Use Disorder.

Authors:  Anna Moszczynska
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.